Mitotic Rate and Younger Age Are Predictors of Sentinel Lymph Node Positivity: Lessons Learned From the Generation of a Probabilistic Model

Vernon K. Sondak, Jeremy M. G. Taylor, Michael S. Sabel, +7

Annals of Surgical Oncology

LongevityImmunologyPathologyBiostatisticsProbabilistic Model +2

Low recurrence rate after surgery for dermatofibrosarcoma protuberans

Derek A. DuBay, Vincent M. Cimmino, Lori Lowe, +2

Cancer

Usefulness of the staged excision for lentigo maligna and lentigo maligna melanoma: The “square” procedure

Timothy M. Johnson, John T. Headington, Shan R. Baker, +1

Journal of the American Academy of Dermatology

Surgical OncologySkin CancerStaged ExcisionSurgical PathologyMelanoma +7

The atypical Spitz tumor of uncertain biologic potential

Mathew W. Ludgate, Douglas R. Fullen, Julia Lee, +5

Cancer

The impact of factors beyond Breslow depth on predicting sentinel lymph node positivity in melanoma

Sandra C. Paek, Kent A. Griffith, Timothy M. Johnson, +8

Cancer

Histological characteristics of metastasizing thin melanomas: a case-control study of 43 cases.

Joan Guitart, Lori Lowe, Michael W. Piepkorn, +7

PubMed

Induction of Abnormal Proliferation by Nonmyelinating Schwann Cells Triggers Neurofibroma Formation

Huarui Zheng, Lou Chang, Neha U. Patel, +4

Cancer Cell

Neuro-oncologyPeripheral NervesTumor InnervationAbnormal ProliferationNeuroscience +4

Dermatofibrosarcoma Protuberans: How Wide Should We Resect?

Jeffrey M. Farma, John B. Ammori, Jonathan S. Zager, +11

Annals of Surgical Oncology

Dermatofibrosarcoma ProtuberansSurgical PathologyHistopathologyPathologyClinical Dermatology +3

Sentinel lymph node biopsy for patients with problematic spitzoid melanocytic lesions

Lyndon D. Su, Douglas R. Fullen, Vernon K. Sondak, +2

Cancer

Features Predicting Sentinel Lymph Node Positivity in Merkel Cell Carcinoma

Jennifer Schwartz, Kent A. Griffith, Lori Lowe, +9

Journal of Clinical Oncology